How can drug discovery for psychiatric disorders be improved?
The DOI matches its Crossref record; 83 of the 83 references it cites were found in a registry or an index.
Abstract
Psychiatric disorders such as depression, anxiety and schizophrenia are leading causes of disability worldwide, and have a huge societal impact. However, despite the clear need for better therapies, and major advances in the understanding of the molecular basis of these disorders in recent years, efforts to discover and develop new drugs for neuropsychiatric disorders, particularly those that might revolutionize disease treatment, have been relatively unsuccessful. A multidisciplinary approach will be crucial in addressing this problem, and in the first Advances in Neuroscience for Medical Innovation symposium, experts in multiple areas of neuroscience considered key questions in the field, in particular those related to the importance of neuronal plasticity. The discussions were used as a basis to propose steps that can be taken to improve the effectiveness of drug discovery for psychiatric disorders.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The mechanistic heterogeneity that potentially underlies the existing classification scheme might be limiting our ability to clarify etiology and identify novel therapeutics for several psychiatric illnesses (3).”
From Distinct neuropsychological subgroups in typically developing youth inform heterogeneity in children with ADHD (2012) · cites this paper as [3]
Citations
Cites
Diagnostic and Statistical Manual of Mental Disorders
Williams, J. B. W., & First, M. (2013) · Encyclopedia of Social Work · doi:10.1093/acrefore/9780199975839.013.104 · Cited by 109,519
Writing Committee Members, Antman, E. M., Anbe, D. T., Armstrong, P. W., Bates, E. R., Green, L. A., Hand, M., Hochman, J. S., Krumholz, H. M., Kushner, F. G., et al. (2004) · Circulation · doi:10.1161/01.cir.0000134791.68010.fa · Cited by 8,356
Neuronal Oscillations in Cortical Networks
Buzsáki, G., & Draguhn, A. (2004) · Science · doi:10.1126/science.1099745 · Cited by 6,576
Self-citationDeep Brain Stimulation for Treatment-Resistant Depression
Mayberg, H. S., Lozano, A. M., Voon, V., McNeely, H. E., Seminowicz, D., Hamani, C., Schwalb, J. M., & Kennedy, S. H. (2005) · Neuron · doi:10.1016/j.neuron.2005.02.014 · Cited by 4,059
Self-citationMayberg, H. S., Liotti, M., Brannan, S. K., McGinnis, S., Mahurin, R. K., Jerabek, P. A., Silva, J. A., Tekell, J. L., Martin, C. C., Lancaster, J. L., et al. (1999) · American Journal of Psychiatry · doi:10.1176/ajp.156.5.675 · Cited by 2,416
Self-citationChanges in grey matter induced by training
Draganski, B., Gaser, C., Busch, V., Schuierer, G., Bogdahn, U., & May, A. (2004) · Nature · doi:10.1038/427311a · Cited by 2,373 · cited 1×
“Specific focal structural changes have been found; for example, related to visuo-spatial memory usage in London taxi-drivers and in training motor skill”
BackgroundDopamine Receptor Binding Predicts Clinical and Pharmacological Potencies of Antischizophrenic Drugs
Creese, I., Burt, D. R., & Snyder, S. H. (1976) · Science · doi:10.1126/science.3854 · Cited by 2,220
Carlsson, A., & Lindqvist, M. (1963) · Acta Pharmacologica et Toxicologica · doi:10.1111/j.1600-0773.1963.tb01730.x · Cited by 2,148
Pezawas, L., Meyer-Lindenberg, A., Drabant, E. M., Verchinski, B. A., Munoz, K. E., Kolachana, B. S., Egan, M. F., Mattay, V. S., Hariri, A. R., & Weinberger, D. R. (2005) · Nature Neuroscience · doi:10.1038/nn1463 · Cited by 1,980
Self-citationLarge-scale recording of neuronal ensembles
Buzsáki, G. (2004) · Nature Neuroscience · doi:10.1038/nn1233 · Cited by 1,875
Self-citation
Research works printed but not linked: 1
- O'Donnell, P. & Grace, A. A. in Review of Psychiatry Vol 18: Schizophrenia in a Molecular Age. Ed. Tamminga, C. A. 109–140 (American Psychiatric Press, Washington DC, 1999).
Cited by
Items 201–241 of 241
The Genome, Genes and Brain – Tailored Drugs
Adler, L. (2010) · Wiley eBooks · doi:10.1002/9780470749180.ch3 · Cited by 1
Biochemical Networks in Psychiatric Disease
Lindskog, M., Halnes, G., Oliveira, R. F., Kotaleski, J. H., & Blackwell, K. T. (2010) · Wiley eBooks · doi:10.1002/9783527630271.ch14 · Cited by 1
Agomelatina: un nuevo enfoque antidepresivo para una remisión de calidad
San, L., & Arranz, B. (2010) · Revista de Psiquiatría y Salud Mental · doi:10.1016/s1888-9891(10)70010-0 · Cited by 1
Serotonin noradrenaline reuptake inhibitors
Bourin, M. (2012) · doi:10.2217/ebo.11.193 · Cited by 2
Overview of Mouse Models for Psychiatric and Neurologic Disorders
Lindner, M. D., & McArthur, R. A. (2011) · Elsevier eBooks · doi:10.1016/b978-0-12-369497-3.10031-7 · Cited by 1
Antidepressants and Major Depressive Disorder
Stein, D. J. (2012) · doi:10.2217/9781780840284 · Cited by 1
Deep Brain Stimulation in Treatment of Refractory Major Depression
Hamani, C., & Holtzheimer, P. E. (2013) · Wiley eBooks · doi:10.1002/9781118346396.ch10 · Cited by 1
Sales, A. J. (2019) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/t.17.2019.tde-27112018-153336 · Cited by 1
Anghelescu, I., & Heuser, I. (2020) · Springer eBooks · doi:10.1007/978-3-030-21573-6_8-1 · Cited by 1
State-of-the-Art of Surgical Therapies for Psychiatric Disorders: Depression
Lozano, A. M. (2009) · Springer eBooks · doi:10.1007/978-3-211-84820-3_89
Barkóczi, B. (2013) · SZTE Repository of Dissertations (University of Szeged) · doi:10.14232/phd.1769 · Cited by 1
Premarketing Efficacy Evaluation
Kelly, J. R. (2009) · Wiley eBooks · doi:10.1002/9780470682920.ch5
Issues and Clues in the Pharmacological Treatment of Mood Disorders
Jollant, F., Ionita, A., & Courtet, P. (2010) · Wiley eBooks · doi:10.1002/9780470749180.ch6
Psychopharmaka-Entwicklung: von der Entdeckung bis zur Zulassung
Anghelescu, I. (2011) · Springer eBooks · doi:10.1007/978-3-642-19844-1_7
Dépression et imagerie cérébrale fonctionnelle
Gaillard, R. (2012) · L Encéphale · doi:10.1016/s0013-7006(12)70073-8
Studies on antidepressant-mediated regulation of signal transduction
Qi, H. (2009) · Figshare
Gene Regulation by Drugs Used to Treat Mood Disorders
Deng, X. (2011) · Otago University Research Archive (University of Otago) · Cited by 2
Introduction to genetic mouse models of neurobehavioral disorders
Pietropaolo, S., Sluyter, F., & Crusio, W. E. (2014) · Cambridge University Press eBooks · doi:10.1017/cbo9781107360556.001
Botvinnik, A. (2009) · eDiss (Georg-August-Universität Göttingen) · doi:10.53846/goediss-3281
Molecular imaging of major depression
Sacher, J., & Smith, G. S. (2010) · Cambridge University Press eBooks · doi:10.1017/cbo9780511782091.012 · Cited by 1
Developing mouse models of neurobehavioral disorders
van der Staay, F. J., Arndt, S. S., & Nordquist, R. E. (2014) · Cambridge University Press eBooks · doi:10.1017/cbo9781107360556.002
Semantic Web Ontology and Data Integration: a Case Study in Aiding Psychiatric Drug Repurposing.
Liang, C., Sun, J., & Tao, C. (2016) · PubMed Central · Cited by 1
Which therapy for which patient?
Greer, T. L., Kurian, B. T., & Trivedi, M. H. (2012) · doi:10.2217/ebo.11.299
Development of a multiplexed RNAi-coupled sensor assay to study neuronal function on the large-scale
Herholt, A. (2017) · eDiss (Georg-August-Universität Göttingen) · doi:10.53846/goediss-6199
Serotonin reuptake and receptor blockers
Ameringen, M. V., Patterson, B. A., & Lee, E. (2012) · doi:10.2217/ebo.11.324
Melatonin receptor agonists/5-HT 2C antagonists
Kennedy, S. H., & Rizvi, S. J. (2012) · doi:10.2217/ebo.11.291
Noradrenaline dopamine-reuptake inhibitors
Silverstone, P. H. (2012) · doi:10.2217/ebo.11.262
San, L., & Arranz, B. (2008) · European psychiatry (Ed Española) · doi:10.1017/s1134066500008869
Colonna, S. (2020) · ORCA Online Research @Cardiff (Cardiff University)
Anghelescu, I., & Heuser, I. (2021) · Springer eBooks · doi:10.1007/978-3-030-57401-7_8
McArthur, R. A., & Borsini, F. (2008) · Elsevier eBooks · doi:10.1016/b978-0-12-373861-5.00033-3
McArthur, R. A., & Borsini, F. (2008) · Elsevier eBooks · doi:10.1016/b978-0-12-373861-5.00034-5
(2012) · doi:10.2217/ebo.11.197
Anghelescu, I. G., & Heuser, I. (2008) · Springer eBooks · doi:10.1007/978-3-540-38918-7_8
Kalra, H., Dean, O. M., Dodd, S., & Berk, M. (2012) · doi:10.2217/ebo.11.273
Dalla, C., Lakhdar‐Ghazal, N., Calvey, T., & Giovanni, G. D. (2024) · Frontiers in Pharmacology · doi:10.3389/fphar.2024.1486719
Khan, M. A., Khan, S., Amin, M. F., & Hossain, M. A. (2026) · Advances in Biomarker Sciences and Technology · doi:10.64898/2026.03.04.709553 · Cited by 1
Functional analysis of the ADHD-susceptibility gene lphn3.1 in zebrafish
Lange, M. (2013) · theses.fr (ABES) · doi:10.70675/c09557dbza44dz4896z87b4z4a9dfe97a9ba
Mariano, A., Rozov, A. V., Phillips, G., Singleton, S., Baptista-Hon, D., Valiullina, F., Sprengel, R., Langston, R. F., Martin, S. J., Hales, T. G., et al. (2026) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2521987123 · Cited by 1
Self-citationBindingDB (2011) · UC San Diego · doi:10.7270/q2gx48x6
Lewis, R. W. (2011) · eCommons (Cornell University)
Metadata
- Authors
- Agid, Y., Buzsáki, G., Diamond, D. M., Frackowiak, R., Giedd, J., Girault, J.-A., Grace, A., Lambert, J. J., Manji, H., Mayberg, H., Popoli, M., Prochiantz, A., Richter-Levin, G., Somogyi, P., Spedding, M., Svenningsson, P., & Weinberger, D.
- Affiliations
- Inserm (FR)
- Rutgers, The State University of New Jersey (US)
- University of South Florida (US)
- National Hospital for Neurology and Neurosurgery (GB)
- National Institutes of Health (US)
- University of Pittsburgh (US)
- University of Dundee (GB)
- Emory University (US)
- University of Milan (IT)
- Centre National de la Recherche Scientifique (FR)
- Karolinska Institutet (SE)
- Corresponding author
- Spedding, Michael
- ORCID
- Venue
- Nature Reviews Drug Discovery
- Published
- 2007-03
- Volume
- 6
- Issue
- 3
- Pages
- 189-201
- ISSN
- 1474-1776 (ISSN-L)
- 1474-1784
- OpenAlex
- W2039643193
- Semantic Scholar
- 6b055b58cc82aab9331b179042a3985bb06b3e33
- Cited by
- 240
- References
- 81
- Citations by year
- 2026: 2 · 2025: 4 · 2024: 5 · 2023: 3 · 2022: 12 · 2021: 7 · 2020: 7 · 2019: 8 · 2018: 10 · 2017: 9 · 2016: 3 · 2015: 8 · 2014: 10 · 2013: 17 · 2012: 30
- FWCI
- 2.73
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature Reviews Drug Discovery (publishedVersion)
- PubMed (publishedVersion)
- Digital Commons - University of South Florida (University of South Florida) (submittedVersion)
- Discovery Research Portal (University of Dundee) (submittedVersion)
- UCL Discovery (University College London) (submittedVersion)
- Topics
- Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
- Keywords
- psychiatric drug discovery, depression, schizophrenia, anxiety, neuropsychiatric disorders, neuroplasticity, translational neuroscience, multidisciplinary approach
- MeSH terms
- Mental Disorders, Consensus Statements as Topic, Humans, Models, Biological, Surveys and Questionnaires, Tranquilizing Agents, Drug Design, Signal Transduction, Practice Guidelines as Topic
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.